Ironwood Pharmaceuticals, Inc. (IRWD)
4.235
+0.10
(+2.54%)
USD |
NASDAQ |
Aug 31, 16:00
4.25
+0.02
(+0.35%)
After-Hours: 20:00
Ironwood Pharmaceuticals Cash from Operations (TTM) : 185.56M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 185.56M |
| March 31, 2026 | 112.21M |
| December 31, 2025 | 127.04M |
| September 30, 2025 | 67.68M |
| June 30, 2025 | 29.98M |
| March 31, 2025 | 78.52M |
| December 31, 2024 | 103.55M |
| September 30, 2024 | 124.17M |
| June 30, 2024 | 146.74M |
| March 31, 2024 | 148.24M |
| December 31, 2023 | 183.43M |
| September 30, 2023 | 226.78M |
| June 30, 2023 | 263.41M |
| March 31, 2023 | 289.81M |
| December 31, 2022 | 273.76M |
| September 30, 2022 | 259.15M |
| June 30, 2022 | 265.12M |
| March 31, 2022 | 252.32M |
| December 31, 2021 | 261.90M |
| September 30, 2021 | 248.84M |
| June 30, 2021 | 227.41M |
| March 31, 2021 | 198.93M |
| December 31, 2020 | 168.84M |
| September 30, 2020 | 144.90M |
| June 30, 2020 | 126.04M |
| Date | Value |
|---|---|
| March 31, 2020 | 96.71M |
| December 31, 2019 | 10.72M |
| September 30, 2019 | -7.582M |
| June 30, 2019 | -68.93M |
| March 31, 2019 | -82.38M |
| December 31, 2018 | -70.88M |
| September 30, 2018 | -88.18M |
| June 30, 2018 | -92.84M |
| March 31, 2018 | -102.60M |
| December 31, 2017 | -99.56M |
| September 30, 2017 | -110.47M |
| June 30, 2017 | -79.37M |
| March 31, 2017 | -53.69M |
| December 31, 2016 | -25.68M |
| September 30, 2016 | -25.51M |
| June 30, 2016 | -51.59M |
| March 31, 2016 | -70.38M |
| December 31, 2015 | -106.33M |
| September 30, 2015 | -110.35M |
| June 30, 2015 | -122.80M |
| March 31, 2015 | -133.46M |
| December 31, 2014 | -155.57M |
| September 30, 2014 | -174.86M |
| June 30, 2014 | -193.64M |
| March 31, 2014 | -237.57M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Rigel Pharmaceuticals, Inc. | 79.39M |
| AbbVie, Inc. | 19.51B |
| Marker Therapeutics, Inc. | -9.756M |
| Theriva Biologics, Inc. | -12.74M |
| Fortress Biotech, Inc. | 120.36M |